Select Medical Holdings Corp

Find Ratings Reports
SEM : NYSE : Health Care
$18.5 | %
Today's Range: 18.0535 - 18.55
Avg. Daily Volume: 728300.0
09/22/17 - 4:02 PM ET

Financial Analysis


SELECT MEDICAL HOLDINGS CORP's gross profit margin for the second quarter of its fiscal year 2017 has increased when compared to the same period a year ago. The company has grown sales and net income during the past quarter when compared with the same quarter a year ago, however, it was unable to keep up with the growth of the average competitor within its industry. SELECT MEDICAL HOLDINGS CORP has average liquidity. Currently, the Quick Ratio is 1.39 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 11.27% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)1120.681097.63
EBITDA ($mil)154.0137.26
EBIT ($mil)115.66101.05
Net Income ($mil)42.0633.94


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)73.878.42
Total Assets ($mil)5054.214838.35
Total Debt ($mil)2794.842744.3
Equity ($mil)848.32956.08


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin17.8916.46
EBITDA Margin13.7412.5
Operating Margin10.329.21
Sales Turnover0.860.88
Return on Assets1.673.04
Return on Equity9.9615.42
Debt Q2 FY17 Q2 FY16
Current Ratio1.531.54
Debt/Capital0.770.74
Interest Expense37.6644.33
Interest Coverage3.072.28


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)132.93131.47
Div / share0.00.0
EPS0.320.26
Book value / share6.387.27
Institutional Own % n/a n/a
Avg Daily Volume753600.0680558.0

Valuation


BUY. SELECT MEDICAL HOLDINGS CORP's P/E ratio indicates a premium compared to an average of 23.06 for the Health Care Providers & Services industry and a premium compared to the S&P 500 average of 24.93. To use another comparison, its price-to-book ratio of 2.87 indicates valuation on par with the S&P 500 average of 3.11 and a discount versus the industry average of 3.28. The current price-to-sales ratio is well below the S&P 500 average and is also below the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
SEM 28.59 Peers 23.06   SEM 11.70 Peers 11.62

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

SEM is trading at a premium to its peers.

 

Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

SEM is trading at a valuation on par to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
SEM 17.26 Peers 16.60   SEM 4.98 Peers 0.68

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

SEM is trading at a premium to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

SEM trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
SEM 2.87 Peers 3.28   SEM -42.86 Peers 21.04

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

SEM is trading at a discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, SEM is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
SEM 0.56 Peers 0.90   SEM 2.02 Peers 8.33

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

SEM is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

SEM significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades